Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscle
Postgraduate Medical Journal · 2024
DOI: 10.1093/postmj/qgae015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, 2024. Verfasst von Mengying Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Children's Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310052, China. Hauptthemen laut MEDLINE: Myasthenia Gravis, Extracellular Vesicles, MicroRNAs, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research on New Technology for Diagnosis and Treatment of Children's Diseases, Children's Hospital of Zhejiang University School of Medicine, Children’s Hospital of Zhejiang University School of Medicine.
Abstract (Originalsprache)
Background
The diagnosis of myasthenia gravis (MG) in children remains difficult. Circulating small extracellular vesicle (sEV)-derived miRNAs (sEV-miRNAs) have been recognized as biomarkers of various diseases and can be excreted by different cell types. These biomarker candidates also play a vital role in autoimmune diseases via intercellular communication.
Methods
In the present study, we used sEV isolation and purification methods to extract the plasma-derived sEV-miRNAs from children with MG and healthy controls. A small RNA sequencing analysis confirmed the miRNA expression features in plasma-derived sEVs from MG patients. The miRNA expression analysis in vitro was determined using microarray analysis. The enrichment and network analyses of altered sEV-miRNAs were performed using miRNA databases and Database for Annotation, Visualization, and Integrated Discovery website. Quantitative real-time polymerase chain reaction was performed for validation of sEV-miRNA. The diagnostic power of altered sEV-miRNAs was evaluated using receiver operating characteristic curve analyses.
Results
Twenty-four sEV-miRNAs with altered expression level were identified between groups by DESeq2 method. The miRNAs were extracted from the sEVs, which were isolated from human primary skeletal muscle cell culture treated with mAb198. The target genes and enriched pathways of sEV-miRNAs partially overlapped between cell supernatant and plasma samples. The significantly downregulated miR-143-3p was validated in quantitative real-time polymerase chain reaction analysis.
Conclusions
For the first time, we report that plasma-derived sEV-miRNAs may act as novel circulating biomarkers and therapeutic targets in pediatric MG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Children's Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310052, China.
- National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou 310052, China.
ORCID-Profile: Feng Gao
Förderung
- Research on New Technology for Diagnosis and Treatment of Children's Diseases
- Children's Hospital of Zhejiang University School of Medicine
- Children’s Hospital of Zhejiang University School of Medicine
Zitieren
APA
Zhu, M., Wang, Y., Xu, X., Guo, X., Mao, Y., & Gao, F. (2024). Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscle. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgae015
Vancouver
Zhu M, Wang Y, Xu X, Guo X, Mao Y, Gao F. Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscle. Postgraduate Medical Journal. 2024. doi:10.1093/postmj/qgae015
BibTeX
@article{Zhu2024,
author = {Zhu, Mengying and Wang, Yilong and Xu, Xuebin and Guo, Xiaotong and Mao, Yuchen and Gao, Feng},
title = {Small extracellular vesicle microRNAs in pediatric myasthenia gravis plasma and skeletal muscle},
journal = {Postgraduate Medical Journal},
year = {2024},
doi = {10.1093/postmj/qgae015}
}
EUVIMED